bu 224 and Alzheimer Disease

bu 224 has been researched along with Alzheimer Disease in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Birch, AM; Davis, N; Golbano, A; Katsouri, L; Mirzaei, N; Mota, BC; Nagy, I; Nutt, DJ; Palmer, EOC; Riggall, LJ; Romero-Molina, C; Sastre, M; Tyacke, R	1

Other Studies

1 other study(ies) available for bu 224 and Alzheimer Disease

Article	Year
Imidazoline ligand BU224 reverses cognitive deficits, reduces microgliosis and enhances synaptic connectivity in a mouse model of Alzheimer's disease. British journal of pharmacology, 2021, Volume: 178, Issue:3 Topics: Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Animals; Cognition; Disease Models, Animal; Female; Imidazoles; Imidazolines; Ligands; Mice; Mice, Inbred C57BL; Mice, Transgenic	2021

Article

Year

Imidazoline ligand BU224 reverses cognitive deficits, reduces microgliosis and enhances synaptic connectivity in a mouse model of Alzheimer's disease.

British journal of pharmacology, 2021, Volume: 178, Issue:3

Topics: Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Animals; Cognition; Disease Models, Animal; Female; Imidazoles; Imidazolines; Ligands; Mice; Mice, Inbred C57BL; Mice, Transgenic

2021